Sponsored by VMG Health | This email address is being protected from spambots. You need JavaScript enabled to view it. | (214) 369-4888

AmSurg Shares Rise in Value After $2.35B Sheridan Deal Announcement

Share on Facebook
Raymond James analyst John Ransom set AmSurg’s price target at $60 and upgraded his recommendation to “buy,” according to a Value Walk report.

The upgrade was made closely following AmSurg’s announcement of intention to acquire Sheridan Healthcare for $2.35 billion.

More Articles on Transactions and Valuation Issues:
4 Recent ASC Industry Acquisitions
Beloit Health System ASC Project Remains in Limbo
3 Recently Opened & Expanded Ambulatory Surgery Centers

© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

New from Becker's ASC Review

S.C. CON program: Where is it now?

Read Now